维普中文期刊产品整合服务
8篇 您的检索式:作者名="Paija"
    题名 作者 年代 出处 被引量
1Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with sinemet CR 显示文摘PAIJA O LAINE K KULTALAHTI E R 2005Clin Neuropharmcol2005,28,3:1
2ImmediateAdministration of Zoledronic Acid Reduces Aro-matase Inhibitor - Associated Bone Loss in Postm-enopausal Women With Early Breast Cancer : 12 一month analysis of the E 一 ZO 一 FAST trial显示文摘Llombart A Frassoldati A Paija O 2012ClinBreast Cancer2012,12,1:1
3Immediate adminis- tration of zoledronic acid reduces aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer: 12-month analysis of the E-ZO-FAST trial显示文摘Llombart A Frassoldati A Paija O 2012Clin Breast Cancer2012,12,1:1
4The ICT cluster,the engine of knowledge-driv-en growth in Finland显示文摘PAIJA L 2001Management Science2001,,7:1
5Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR显示文摘PAIJA O LAINE K KULTALAHTI E R 2005Clin Neuropharmacol2005,28,3:1
6Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR显示文摘PAIJA O LAINE K KULTALAHTI E R 2005Clin Neuropharmacol2005,28,3:1
7Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR显示文摘Paija O Laine K Kultalahti ER 2005Clin Neuropharmacol2005,28,:1
8Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial显示文摘Antonio Llombart Antonio Frassoldati Outi Paija Harm Peter Sleeboom Guy Jerusalem Jeroen Mebis Ines Deleu Joel Miller Nora Schenk Patrick Neven 2012Clinical Breast Cancer2012,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费